![Kristine Peterson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kristine Peterson
Directeur/Membre du Conseil chez
IMMUNOCORE HOLDINGS PLC
Fortune : - $ au 31/05/2026
Profil
Kristine Peterson is currently Independent Director at Enanta Pharmaceuticals, Inc. since 2017, Director at Greater Philadelphia Life Sciences Congress, Director at AFYX Therapeutics AS, Independent Non-Executive Director at Immunocore Holdings Plc since 2017, Non-Executive Director at Immunocore Ltd., and Lead Independent Director at Arrivent BioPharma, Inc. starting in 2025.
Former roles include Chief Executive Officer at Valeritas Holdings, Inc. from 2009 to 2016, Chief Executive Officer & Director at Valeritas, Inc. from 2009 to 2016, Group Chairman-Biotech Group at Johnson & Johnson from 2006 to 2009, Independent Director at ImmunoGen, Inc. from 2012 to 2024, Independent Non-Executive Director at Amarin Corp.
Plc from 2010 to 2023, Director at Biotechnology Innovation Organization, Independent Non-Executive Director at EyePoint, Inc. from 2017 to 2020, Independent Director at Paratek Pharmaceuticals, Inc. from 2016 to 2023, Principal at Bristol Myers Squibb Co., President & Senior VP-Commercial Operations at Biovail Corp.
from 2003 to 2004, and President at Biovail Pharmaceuticals LLC from 2003 to 2004.
Education includes undergraduate and MBA degrees from the University of Illinois At Urbana–Champaign, conferred in 1981 and 1983 respectively.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 18/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 11/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Kristine Peterson
| Sociétés | Poste | Début |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 13/09/2017 |
| IMMUNOCORE HOLDINGS PLC | Directeur/Membre du Conseil | 01/11/2017 |
| ARRIVENT BIOPHARMA, INC. | Directeur/Membre du Conseil | 20/04/2024 |
AFYX Therapeutics AS
 AFYX Therapeutics AS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur/Membre du Conseil | - |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Directeur/Membre du Conseil | - |
Greater Philadelphia Life Sciences Congress | Directeur/Membre du Conseil | 08/04/2011 |
Anciens postes connus de Kristine Peterson
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNOGEN, INC. | Directeur/Membre du Conseil | 12/02/2024 |
| PARATEK PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 21/09/2023 |
| AMARIN CORPORATION PLC | Directeur/Membre du Conseil | 06/03/2023 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Kristine Peterson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Biovail Corp.
 Biovail Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Valeritas Holdings, Inc.
 Valeritas Holdings, Inc. Medical SpecialtiesHealth Technology Develops and commercializes insulin drug delivery devices | Health Technology |
EyePoint Pharmaceuticals, Inc.
 EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Enanta Pharmaceuticals, Inc.
 Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
Valeritas, Inc.
 Valeritas, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug delivery solutions for the treatment of diabetes | Health Technology |
Biovail Pharmaceuticals LLC
 Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical medicines | Health Technology |
Greater Philadelphia Life Sciences Congress | |
Paratek Pharmaceuticals, Inc.
 Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
AFYX Therapeutics AS
AFYX Therapeutics AS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Arrivent BioPharma, Inc.
 Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Health Technology |
Choisissez Zonebourse 
